000 | 04995nam a22004935i 4500 | ||
---|---|---|---|
001 | 978-981-19-1854-4 | ||
003 | DE-He213 | ||
005 | 20240729133902.0 | ||
007 | cr nn 008mamaa | ||
008 | 220808s2022 si | s |||| 0|eng d | ||
020 |
_a9789811918544 _9978-981-19-1854-4 |
||
024 | 7 |
_a10.1007/978-981-19-1854-4 _2doi |
|
072 | 7 |
_aPSA _2bicssc |
|
072 | 7 |
_aSCI086000 _2bisacsh |
|
072 | 7 |
_aPSA _2thema |
|
245 | 1 | 0 |
_aAlternatives to Antibiotics _b : Recent Trends and Future Prospects / |
250 | _a1st ed. 2022. | ||
264 | 1 |
_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer, _c2022. |
|
300 |
_aXXIII, 571 p. 70 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
505 | 0 | _aChapter 1. Quest for alternatives to antibiotics - an urgent need of the 21st century -- Chapter 2. Phytochemicals as antibacterial agents: current status and future perspective -- Chapter 3. Quorum quenching enzymes: a potent alternative to conventional antibiotics -- Chapter 4. Antibodies as antibacterial molecules: the new era of antibody-mediated immunity -- Chapter 5. Phage therapy: genomics to applications and future prospects -- Chapter 6. Alternatives to antibiotics in animal farming -- Chapter 7. Metal catalysed synthesis of b-lactam antibiotics -- Chapter 8. Upgrading the antibiotic arsenal against gram-positive bacteria: chemical modifications of vancomycin -- Chapter 9. Heterocyclic scaffolds in novel synthetic antibacterial agents -- Chapter 10. Antibacterial metal-organic frameworks -- Chapter 11. Cationic amphiphilic molecules as bactericidal agents -- Chapter 12. Polymeric nanoparticles and nanocomposites as antibacterial agents -- Chapter 13. Metallic nanoparticles and their composites as alternative antibacterial therapeutics -- Chapter 14. Carbon nanoparticles as the next generation antimicrobial agents -- Chapter 15. Dendrimeric entities as chemical alternatives towards antimicrobial therapy -- Chapter 16. Ionic liquids, ionic liquid nanoparticles and nanocomposites-the future antibiotics -- Chapter 17. Prebiotic immunomodulators to enhance mucosal immunity and to reduce mass use of antibiotics -- Chapter 18. Use of probiotics, prebiotics and synbiotics as an alternative to antibiotics -- Chapter 19. The implication of antimicrobial peptides against bacteria and their clinical aspects -- Chapter 20. development of probiotics for helocibacter pylori infection management -- Chapter 21. Implications of probiotics in management of bacterial infections -- Chapter 22. Nano carriers for the molecular targeting of pathogenic bacteria. | |
520 | _aThis book discusses prospective alternative approaches to fight bacterial infections to minimize the indiscriminate use of conventional antibiotics. It offers the current knowledge on research and development of alternative antibacterial agents such as probiotics, nanobiotics etc. while it also discusses newly emerging trends such as phage therapy, antibody therapy etc. The book highlights on the phytochemicals with potent antibacterial activities as alternatives to conventional antibiotics. Chemical modification to develop next generation antibiotics with enhanced efficacy has also been included. Such modifications are reported to overcome the inherent resistance of the parent antibiotics. Phage therapy and targeted antibodies are considered as potential alternative approaches to treat bacterial ailments and represent areas of cutting-edge research and have therefore been discussed with sufficient care. Mainly, the book highlights various approaches other than conventional antibiotics in treating bacterial infections. The scientific advancements in these areas will strengthen the 'One Health' approach benefiting human beings, animals and environment as well. This book is a comprehensive resource to cater researchers, biological scientists, herbalists and clinical practitioners with up-to-date information on antibacterials other than antibiotics. | ||
650 | 0 |
_aBiology. _95385 |
|
650 | 0 | _aImmunology. | |
650 | 0 | _aNanomedicine. | |
650 | 0 | _aAlternative medicine. | |
650 | 1 | 4 | _aBiological Sciences. |
650 | 2 | 4 | _aImmunology. |
650 | 2 | 4 | _aNanomedicine and Nanotoxicology. |
650 | 2 | 4 | _aComplementary and Alternative Medicine. |
700 | 1 |
_aSaha, Tilak. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aDeb Adhikari, Manab. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aTiwary, Bipransh Kumar. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
856 |
_u#gotoholdings _yAccess resource |
||
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
245 | _h[E-Book] | ||
999 |
_c100889 _d100889 |